Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-25-308375
Filing Date
2025-12-04
Accepted
2025-12-04 20:27:13
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 24888
2 EX-1.B ck0000000000-ex1_b.pdf EX-1.B 21752
3 EX-99.18 ck0000000000-ex99_18.pdf EX-99.18 379419
4 EX-99.19 ck0000000000-ex99_19.pdf EX-99.19 116522
  Complete submission text file 0001193125-25-308375.txt   740065
Mailing Address IDA BUSINESS PARK BRAY WICKLOW Ireland
Business Address IDA BUSINESS PARK BRAY WICKLOW Ireland 01135312955111
TRINITY BIOTECH PLC (Subject) CIK: 0000888721 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-44122 | Film No.: 251550996
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 85 ORCHARD ROAD SKILLMAN NJ 08558
Business Address 85 ORCHARD ROAD SKILLMAN NJ 08558 8464705596
MiCo IVD Holdings, LLC (Filed by) CIK: 0001952094 (see all company filings)

EIN.: 881399456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A